shutterstock_1427552003_art_studio_g
Art studio G / Shutterstock.com
13 April 2023FeaturesAmericasLívia Figueiredo and Priscila Kashiwabara

Brazil: The patent combination conundrum

Patents to new medicines usually protect the active ingredient (compound), provided that it is new and inventive. It is also a common practice for pharmaceutical companies to seek patent protection for drug combinations, which can be especially valuable for providing a competitive advantage over other companies that are developing single-component drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
26 May 2026   Two days of discussions at LSPN North America revealed an industry grappling with narrower patent claims, global strategy changes, AI disruption and tougher dealmaking conditions.
Americas
26 May 2026   Ahead of WIPR Trade Secrets West, Cooley partner Heidi Keefe says that for legal teams, caution—not business pressure—should be the priority.
Americas
22 May 2026   A US appeals court has handed the generic drugmaker victory in a closely watched dispute over a treatment for a serious inherited kidney condition, dealing a setback to its branded rival.